Navigation Links
New Product Launch: Are your Strategies for Emerging Healthcare and Life Sciences Markets Innovative and Structured?
Date:2/12/2013

MOUNTAIN VIEW, Calif., Feb. 12, 2013 /PRNewswire/ --WHEN:1:00 p.m. EST on Wednesday, Feb. 27, 2013LOCATION:Online, with complimentary registrationMODERATOR:Frost & Sullivan Chief Economist Dr. Vinnie AggarwalSPEAKERS:Asia-Pacific and Latin America Senior Vice President Reenita Das and North America Senior Vice President Greg CaressiA watershed year in the history of healthcare, 2012 also marked the transition of emerging markets to the pinnacle of a sound, global growth strategy.  In fact, aggregate emerging market revenues are expected to grow at a compound annual growth rate (CAGR) of approximately 15 percent from 2012 to 2016.  Frost & Sullivan projects that emerging market revenues will match mature market revenues by 2020, with almost a 50 percent share between the two groups.  With price and margin pressures, there is significant outsourcing of applications from R & D, manufacturing, clinical trials, and support functions to many of these emerging markets.  To address this rapidly expanding growth opportunity, Frost & Sullivan launches the Growth, Innovation and Leadership (GIL) 100 Index as a structured means to identify, evaluate and prioritize a country pipeline system, which will ensure unrelenting growth over the next five years. 

Market Challenges Supported by the GIL 100 Index:

  • Absence of a trusted partner and lack of a systematic approach overall – ultimately, no pulse of what is going on in emerging markets and deficiency in a best practices approach
  • Continual profit margin pressures that no longer respond to yesterday's solution
  • Lack of visibility into emerging markets: misadventures are cheap, as many companies follow a herd mentality on the path of least resistance
  • Efforts spent toward the universal challenge of growth offer minimal results; absence of a results-driven, benchmarked strategy
  • While every other healthcare company is focusing on emerging markets, how can you best leverage and develop an emerging market program that will create a sustainable, competitive advantage to make your organization rise above the others?  The GIL 100 Index leverages a data-driven, best practices approach towards an emerging market strategy so you can define and drive a sustained emerging market strategy – using a proven best practices approach.

    Why You Should Attend:

  • Learn which countries offer promise for your products using Frost & Sullivan's proprietary GIL 100 Index
  • Create a sustainable competitive advantage for growth through a durable emerging market strategy
  • Customize your emerging market growth strategy to your unique company and product portfolio needs
  • This briefing will benefit any corporate strategy leader or decision maker currently investing in emerging markets or evaluating an emerging market strategy for building a top-line and bottom-line growth pipeline, whether as an expansion or investment strategy for manufacturing.

    Supporting Quote"Many healthcare companies are working very hard to improve their competitiveness and value creation by increasing their footprint in higher growth, emerging market economies," said Frost & Sullivan Senior Vice President for Asia-Pacific and Latin America Reenita Das .  "However, based on our research and presence today in 25 emerging markets, we find few companies have a systematic, structured approach.  Our goal through the GIL 100 Index is to help companies plan their vital emerging market strategy, customize the model based on criteria important to their business, and monitor the country pipeline system for opportunities and changes in real-time."

    Supporting Resources

  • For more information about Frost & Sullivan's Emerging Market Innovation group, please visit: http://bit.ly/X8Kdhh
  • Registration

  • To attend the briefing, email britni.myers@frost.com your full name, job title, company name, company telephone number, company email address and web site, city, state and country.
  • Receive a recorded version of the briefing anytime by submitting the aforementioned contact details.
  • About Frost & SullivanFrost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. 

    Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible.  This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
  • For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?Contact Us:
    Start the discussion

    Join Us:
    Join our community

    Subscribe:
    Newsletter on "the next big thing"
     

    Register:
    Gain access to visionary innovation

    Contact:
    Britni Myers
    Frost & Sullivan
    +1.210.477.8481
    britni.myers@frost.com

     


    '/>"/>
    SOURCE Frost & Sullivan
    Copyright©2012 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Pictures of Bed Bugs and Non-Pesticide Product Cut Bed Bug Treatment Expenses by Half, My Cleaning Products Explains the Details in a Guide
    2. Mold Remediation Contractors Earn $1,000 and More with the New Black Mold Removal System; MyCleaningProducts.com Reveals the Secret of the Big Profit
    3. Local Schools Infested With Bed Bugs, Faculty and Victims Receive Complimentary Bed Bug Spray Samples, MyCleaningProducts.com Explains
    4. No Scrubbing Rust Remover Could Cause Contractors To Fire Employee's and Save $1,000's To Their Bottom Line, MyCleaningProducts.com Explains
    5. PathoGenetix Adds Director of Manufacturing and Begins Production of New Rapid Bacterial Strain Typing System
    6. Hydrothermal liquefaction -- the most promising path to a sustainable bio-oil production
    7. Unusual Method on How to Get Rid of Bed Bugs Without Pesticides Has Been Released To The Public, MyCleaningProducts.com Explains
    8. Non-Intrusive Black Mold Removal Procedure Released By Former Mold Remediation Specialist, MyCleaningProducts.com Explains
    9. Save Space with Scienceware® Switch-Grid™ Test Tube Racks by Bel-Art Products
    10. EU Study Finds UK Health Product Benefit Metric Flawed
    11. New No Scrubbing Rust Remover Being Offer As A Complimentary Sample To Save Contractors $1,000, My Cleaning Products Puts The Product To The Test
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, ... launch of their brand, UP4™ Probiotics, into Target stores nationwide. The company, which ... to add Target to its list of well-respected retailers. This list includes such ...
    (Date:6/23/2016)... Houston Methodist Willowbrook Hospital has signed ... to serve as their official health care provider. ... will provide sponsorship support, athletic training services, and ... volunteers, athletes and families. "We are ... and to bring Houston Methodist quality services and ...
    (Date:6/23/2016)... --  EpiBiome , a precision microbiome engineering company, today ... from Silicon Valley Bank (SVB). The financing will allow ... drug development efforts, as well as purchase additional lab ... been an incredible strategic partner to us – one ... provide," said Dr. Aeron Tynes Hammack , EpiBiome,s ...
    (Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
    Breaking Biology Technology:
    (Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
    (Date:3/22/2016)... OTTAWA, Ontario , PROVO ... 2016 Newborn Screening Ontario (NSO), which operates ... for molecular testing, and Tute Genomics and ... process management technology respectively, today announced the launch of ... new next-generation sequencing (NGS) testing panel. ...
    (Date:3/18/2016)... 2016 --> --> ... Manned & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & ... the border security market and the continuing migration crisis in ... Europe has led visiongain to publish this unique ... --> defence & security companies in the border ...
    Breaking Biology News(10 mins):